Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the overall safety and tolerability profile of two dose levels of DVS-233 SR
during 6 months of open-label treatment in elderly outpatients with major depressive
disorder.